For Doctors

BOWEL CANCER SCREENING IN INDIVIDUALS WITH A FAMILY HISTORY – Updated Clinical Guidelines


In October 2023, updates were made to the NHMRC-endorsed clinical guidelines regarding bowel cancer screening. These revisions aim to enhance the effectiveness of screening strategies and improve outcomes for those at increased risk. The updated guidelines emphasise the importance of tailoring screening recommendations based on an individual’s specific risk factors, including their family history of […] Read more...

VITAMIN B12 DEFICIENCY & ENDOSCOPY


Vitamin B12 deficiency can be a clinical indicator of various gastrointestinal disorders, and whether it warrants an endoscopy depends on the patient’s overall clinical picture and associated...

Read more...

NEW IBD DRUGS & THE RISK OF SHINGLES


The landscape of Inflammatory Bowel Disease (IBD) treatment is evolving, with Janus kinase (JAK) inhibitors like Tofacitinib and Upadacitinib emerging as effective oral therapies. These drugs offer a...

Read more...